WOUND DRESSING WITH SELECTIVE AND DYNAMIC TRANSPARENCY
A selectively transparent wound therapy dressing, system, and method of use are provided. The dressing may include conformable foam and drape layers, wherein the drape layer has a refractive index substantially within a range of a disclosing liquid. When the disclosing liquid is applied to the drape layer, the drape layer may switch from opaque to transparent. Subsequent evaporation of the disclosing liquid may return the drape layer to an opaque state. Some embodiments provide for paired use with a negative pressure source input device. The method of use provides selective visibility of a treatment site, and reduces the amount of time in which a patient views an acute or traumatic wound or injury.
1 . A wound therapy dressing comprising:
a foam layer, and
a drape layer comprising a material having a refractive index substantially within a range of 1.3 to 1.55.
2 . The wound therapy dressing of claim 1 , wherein the foam layer is substantially transparent.
3 . The wound therapy dressing of claim 1 , wherein the foam layer is white.
4 . The wound therapy dressing of claim 1 , wherein the drape layer comprises a fabric comprising fine fibered polymers.
5 . The wound therapy dressing of claim 1 , wherein the fine fibered polymers comprise elastic materials.
6 . The wound therapy dressing of claim 5 , wherein the elastic materials comprise polyvinylidene fluoride (PVF), polyvinylidene difluoride (PVDF), ethylene-vinyl acetate, thermoplastic polyurethane, thermoplastic elastomer, thermoplastic vulcanizate, polyether block amide, polyamides, polyethyleneimines, or polyester.
7 . The wound therapy dressing of claim 1 , wherein the drape layer comprises porous or microporous particles.
8 . The wound therapy dressing of claim 7 , wherein the porous or microporous particles comprise minerals or polymers.
9 . The wound therapy dressing of claim 8 , wherein the minerals comprise silica, silicates, fluorites, or fluorides.
10 . The wound therapy dressing of claim 8 , wherein the polymers comprise fluoropolymers, silicones, or acrylics.
11 .- 43 . (canceled)
44 . A method for wound therapy comprising:
(i) applying to a treatment site a wound therapy system comprising:
a conformable, transparent foam dressing layer; and
a conformable, selectively-transparent drape layer configured to extend over and adhere the transparent foam dressing layer to a treatment site;
(ii) applying a disclosing liquid with a refractive index within a range of the refractive index of the drape layer to the drape layer, wherein the selectively-transparent drape layer changes from a first, opaque state to a second, transparent state;
(iii) observing the treatment site while the drape layer remains in the transparent state; and
(iv) allowing the disclosing liquid to evaporate, whereby the drape layer returns to an opaque state.
45 . The method of claim 44 , wherein a patient only sees the treatment site when being examined by a medical practitioner.
46 . The method of claim 44 , wherein a medical practitioner monitors healing at the periwound of a treatment site.
47 . The method of claim 44 , wherein the system further comprises a negative pressure wound input device.
48 . The method of claim 47 , wherein the negative pressure wound input device couples to a hole in the drape layer through which air is withdrawn from the treatment site.